{"id":898287,"date":"2025-10-21T11:49:02","date_gmt":"2025-10-21T15:49:02","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/"},"modified":"2025-10-21T11:49:02","modified_gmt":"2025-10-21T15:49:02","slug":"important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/","title":{"rendered":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf"},"content":{"rendered":"
\n

PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — <\/p>\n

\n
\n Baxter International Inc. (NYSE: BAX):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased Baxter International Inc. (NYSE: BAX)<\/strong>
\n shares prior to <\/strong>
\n February 23, 2022,<\/strong>
\n and still hold shares today, you <\/strong>
\n can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Baxter shares between <\/strong>
\n February 23, 2022 and July 30, 2025, you can participate in the class action. <\/strong>
\n Visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/baxter-shareholder-investigation\/<\/strong>
\n <\/a>
\n ,<\/strong>
\n contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call us at 267-507-6085. <\/strong>\n <\/p>\n

\n WHY?<\/strong> A recently filed securities fraud class action complaint alleges that Baxter International Inc. (NYSE: BAX), through certain of its officers and directors, made material misrepresentations to investors by portraying its Novum LVP as safe, while concealing systemic issues that put patients at risk of severe injury and death. Prior to launching the Novum LVP in the United States, Defendants assured investors that Baxter \u201c[was] able to address all of [the] issues\u201d that came up with the initial rollout in Canada, and that the U.S. launch would not be subject to the same issues. While the Novum LVP was rolling out in the United States, Defendant Jose Almeida, Baxter\u2019s former Chief Executive Officer, further assured investors that the launch was \u201cgoing extremely well\u201d and \u201cone of the best launches that [he\u2019s] seen in [his] career.\u201d In reality, the launch was on the brink of failure due to recurring life-threatening defects in the devices that Baxter could not adequately correct.<\/p>\n

Specifically, safety concerns regarding Novum LVP began to surface on April 7, 2025 when a Missouri news outlet reported serious safety issues relating to inaccurate infusion rates with the Novum LVPs based on information from a whistleblower at a local hospital system. According to the whistleblower, \u201cpatients should not be being treated with these pumps. These pumps are not safe.\u201d When asked if any potential fixes to the safety issues had been sufficient, the whistleblower replied, \u201cno, they have all been Band-Aid solutions.\u201d This report prompted the hospital system to take all its Novum LVPs out of service. Notwithstanding the whistleblower report, Baxter did not formally respond to multiple requests for comments and instead continued to tout the Novum LVPs as safe products with a successful launch. Major national news outlets did not pick up the story, allowing Baxter to contain the fallout and continue misleading investors about the success of the Novum LVP rollout. This was followed by customer warning letters and then an FDA classification of these issues as a Class I recall, its most serious designation, reflecting a risk of severe injury or death. Finally, on July 31, 2025, the true extent of the safety issues was revealed to the market when Baxter announced the suspension of all new Novum LVP sales.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n Current Baxter shareholders who have held Baxter <\/strong>
\n shares since prior to February 23, 2022, <\/strong>
\n can <\/strong>
\n seek corporate reforms, the return of funds spent defending litigation back to the company, and a court approved incentive award, at no cost to them whatsoever. Visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/baxter-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>
\n contact Joshua Grabar at\u00a0<\/strong>
\n
\n
\n jgrabar@grabarlaw.com<\/u>
\n <\/strong>
\n <\/a>
\n
\n ,<\/u>
\n <\/strong>
\n or call 267-507-6085<\/strong>
\n to learn more. <\/strong>Alternatively, if you purchased Baxter shares between February 23, 2022, and July 30, 2025, you can participate in the class action. $BAX #Baxter<\/p>\n

\n
\n Five Below, Inc. (NASDAQ: FIVE) \u2013 Class Action Survives Motion to Dismiss<\/u>
\n <\/strong>
\n :<\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Five Below, Inc. (NASDAQ: FIVE) as allegations in a securities fraud class action have survived a motion to dismiss the complaint<\/strong>. The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n Current Five Below, Inc. (NASDAQ: FIVE) shareholders who have held Five Below shares since prior to December 1, 2022<\/strong>, can <\/strong>seek corporate reforms, the return of funds back to the company, and a court approved incentive award<\/strong>at no cost to them whatsoever<\/strong>. Click here to learn more:<\/strong>https:\/\/grabarlaw.com\/the-latest\/five-shareholder-investigation\/<\/strong><\/a>, contact Joshua Grabar at <\/strong>jgrabar@grabarlaw.com<\/strong><\/a>, or call us at 267-507-6085. <\/strong><\/p>\n

Why?<\/strong>Key allegations of a securities fraud class action complaint against, Five Below, Inc. (NASDAQ: FIVE), and certain of its officers, have survived a motion to dismiss.<\/strong> The underlying complaint alleges that, Five Below, Inc., via certain of its officers and directors, provided investors with false and\/or materially misleading information about Five Below\u2019s financial strength and operations, including its outlook for the first quarter and full year 2024. On June 5, 2024, Five Below announced disappointing first quarter 2024 sales result and cut its full year 2024 guidance stating, “Net sales are expected to be in the range of $3.79 billion to $3.87 billion based on opening approximately 230 new stores.” At the same time, Five Below claimed that for the second quarter, “Net sales are expected to be in the range of $830 million to $850 million based on opening approximately 60 new stores.” In response to the disclosure, Five Below ‘s stock price declined $14.07 per share within the span of just one day.<\/p>\n

On August 25, 2025, key allegations of the underlying class action survived defendants\u2019 motion to dismiss the complaint. \u00a0In so holding, the court determined that: \u201cPlaintiffs plausibly allege that during the class period, Five Below was having serious issues executing on their trend-right strategy and stocking trending items in stores. There is substantial former employee testimony supporting this point.\u201d Moreover, certain statements regarding \u201cthe extent and cause of shrink are material to investors, misleading by omission, and thus actionable under the PSLRA.\u201d<\/p>\n

\n What You Can Do Now:<\/strong>
\n If you<\/strong>
\n have held Five Below (NASDAQ: FIVE) shares since prior to December 1, 2022, and would like to learn more at no cost to you, please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/five-shareholder-investigation\/<\/strong>
\n <\/a>
\n , <\/strong>
\n contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , or call us at 267-507-6085. You can <\/strong>
\n seek corporate reforms, the return of funds back to company coffers, and potentially a receive a court approved incentive award at no cost to you whatsoever. <\/strong>$FIVE #FiveBelow<\/p>\n

\n
\n Humana Inc.\u00a0(NYSE: HUM)<\/u>
\n <\/strong>
\n :<\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Humana Inc.\u00a0(NYSE: HUM). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased <\/strong>
\n Humana Inc.\u00a0(NYSE: HUM), <\/strong>
\n shares prior to <\/strong>
\n July 27, 2022,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>
\n
\n Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/humana-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085 to learn more. <\/strong><\/p>\n

WHY?<\/strong> As alleged in a recently filed federal securities fraud class action complaint, Humana Inc. (NYSE: HUM), through certain of its officers, made materially false and\/or misleading statements, as well as failed to disclose material adverse facts, about the Company\u2019s business and operations. Specifically, the Complaint alleges Defendants downplayed pressures on the Company\u2019s adjusted EPS resulting from increased medical costs associated with pent-up demand for healthcare procedures (especially as COVID concerns abated) which, contrary to the Company\u2019s assurances, resulted in increased utilization rates and costs.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased <\/strong>
\n Humana Inc.\u00a0(NYSE: HUM), <\/strong>
\n shares prior to <\/strong>
\n July 27, 2022,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/humana-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong> #HUM $HUM #Humana<\/p>\n

\n
\n Ibotta, Inc. (NYSE: IBTA):<\/u>
\n <\/strong>\n <\/p>\n

Grabar Law Office is investigating claims on behalf of shareholders of Ibotta, Inc. (NYSE: IBTA). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company.<\/p>\n

\n If you purchased Ibotta, Inc. shares on or shortly after the company\u2019s April 18<\/strong>
\n , 2024 IPO,<\/strong>
\n and still hold shares today, <\/strong>
\n you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Please visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085, to learn more.<\/strong><\/p>\n

WHY?<\/strong> A federal securities fraud class action complaint alleges that statements made in Ibotta Inc\u2019s (NYSE: IBTA) Registration Statement issued in connection with Ibotta\u2019s April 18, 2024 initial public offering were false and\/or misleading when made because they did not properly warn investors of the risks concerning Ibotta\u2019s contract with The Kroger Co. Kroger\u2019s contract was at-will, and Ibotta failed to warn investors that a large client could cancel their contract with Ibotta without warning. Despite providing a detailed explanation of the terms of Ibotta\u2019s contract with Walmart, there was not a single warning of the at-will nature of Kroger\u2019s contract.<\/p>\n

\n WHAT YOU CAN DO NOW:<\/strong>
\n If you purchased Ibotta, Inc. (NYSE: IBTA) shares on or shortly after the company\u2019s April 18<\/strong>
\n , 2024 IPO,<\/strong>
\n and still hold shares today, <\/strong>
\n you are encouraged to visit <\/strong>
\n
\n https:\/\/grabarlaw.com\/the-latest\/ibotta-shareholder-investigation\/<\/strong>
\n <\/a>
\n , contact Joshua Grabar at <\/strong>
\n
\n jgrabar@grabarlaw.com<\/strong>
\n <\/a>
\n , <\/strong>
\n or call 267-507-6085. You can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever.<\/strong>\u00a0\u00a0 $IBTA #IBTA #Ibotta<\/p>\n

\n Attorney Advertising Disclaimer<\/a>\n <\/p>\n

Contact:
Joshua H. Grabar, Esq.
Grabar Law Office
One Liberty Place
1650 Market Street, Suite 3600
Philadelphia, PA 19103
Tel: \u00a0267-507-6085
Email: jgrabar@grabarlaw.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Baxter International Inc. (NYSE: BAX): Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Baxter International Inc. (NYSE: BAX) shares prior to February 23, 2022, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Baxter shares between February 23, 2022 and July 30, 2025, you can participate in the class action. Visit https:\/\/grabarlaw.com\/the-latest\/baxter-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or … <\/p>\n

Continue reading “Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-898287","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nImportant Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Baxter International Inc. (NYSE: BAX): Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Baxter International Inc. (NYSE: BAX) shares prior to February 23, 2022, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Baxter shares between February 23, 2022 and July 30, 2025, you can participate in the class action. Visit https:\/\/grabarlaw.com\/the-latest\/baxter-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or … Continue reading "Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-21T15:49:02+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"8 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf\",\"datePublished\":\"2025-10-21T15:49:02+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/\"},\"wordCount\":1617,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/\",\"name\":\"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=\",\"datePublished\":\"2025-10-21T15:49:02+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/","og_locale":"en_US","og_type":"article","og_title":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","og_description":"PHILADELPHIA, Oct. 21, 2025 (GLOBE NEWSWIRE) — Baxter International Inc. (NYSE: BAX): Grabar Law Office is investigating claims on behalf of shareholders of Baxter International Inc. (NYSE: BAX). The investigation concerns whether certain officers and directors breached the fiduciary duties they owed to the company. If you purchased Baxter International Inc. (NYSE: BAX) shares prior to February 23, 2022, and still hold shares today, you can seek corporate reforms, the return of funds back to the company, and a court approved incentive award at no cost to you whatsoever. Alternatively, if you purchased Baxter shares between February 23, 2022 and July 30, 2025, you can participate in the class action. Visit https:\/\/grabarlaw.com\/the-latest\/baxter-shareholder-investigation\/ , contact Joshua Grabar at jgrabar@grabarlaw.com , or … Continue reading \"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-21T15:49:02+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"8 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf","datePublished":"2025-10-21T15:49:02+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/"},"wordCount":1617,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/","name":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=","datePublished":"2025-10-21T15:49:02+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU0OTIxNCM3MjA2NTY0IzIyMDEyNzA="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-notice-to-long-term-shareholders-of-baxter-international-inc-nyse-bax-five-below-inc-nasdaq-five-and-humana-inc-nyse-hum-and-ibotta-inc-nyse-ibta-grabar-law-office-is-i\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Important Notice to Long-Term Shareholders of Baxter International Inc. (NYSE: BAX); Five Below, Inc. (NASDAQ: FIVE); and Humana Inc. (NYSE: HUM); and Ibotta, Inc. (NYSE: IBTA): Grabar Law Office is Investigating Claims on Your Behalf"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/898287","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=898287"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/898287\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=898287"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=898287"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=898287"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}